Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

Building a culture of compliance around respiratory protection no longer relies on guesswork. CleanSpace is making it ...

DUBAI – In a solid executive action that is in accordance with the UAE's National Strategy for Artificial Intelligence 2031, ...

Researchers are cautioning against relying solely on glycated haemoglobin, ‘HbA1c’, for diagnosing and monitoring diabetes in ...

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

For decades, medical research has treated the human genome as the master blueprint for understanding disease. But a growing body of evidence suggests that what happens outside our cells, the sum total ...

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how ...

Climate change is one of the principal driving forces intensifying abiotic stresses such as drought, salinity, flood and extreme heat and cold temperatures.

Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team ...

Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...